摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-3-(Cbz-氨基)-2-氧代氮杂烷 | 103478-12-2

中文名称
(S)-3-(Cbz-氨基)-2-氧代氮杂烷
中文别名
(S)-2-氧代-3-(CBZ-氨基)氮杂环庚烷
英文名称
(3S)-3-benzyloxycarbonylamino-2-perhydroazepinone
英文别名
benzyl (S)-(2-oxoazepan-3-yl)carbamate;((S)-2-oxo-hexahydro-azepin-3-yl)-carbamic acid benzyl ester;((S)-2-Oxo-hexahydro-azepin-3-yl)-carbamidsaeure-benzylester;3(S)-benzyloxycarbonylamino-2-caprolactam;benzyl N-[(3S)-2-oxoazepan-3-yl]carbamate
(S)-3-(Cbz-氨基)-2-氧代氮杂烷化学式
CAS
103478-12-2
化学式
C14H18N2O3
mdl
——
分子量
262.309
InChiKey
ZFWYCTUOFGJWRJ-LBPRGKRZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    116 °C(Solv: cyclohexane (110-82-7))
  • 沸点:
    510.1±49.0 °C(Predicted)
  • 密度:
    1.19±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    67.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933790090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:f111e43a47f5c3d20813afa2f22fb3f1
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-3-(Cbz-氨基)-2-氧代氮杂烷正丁基锂三氯氧磷 作用下, 以 正己烷 为溶剂, 生成
    参考文献:
    名称:
    Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors
    摘要:
    The structure of sulphostin (1). a novel dipeptidyl peptidase IV (DPP-IV) inhibitor, is consisted of three key functional groups, including a characteristic amino(sulfoamino)phosphinyl group, on a piperidine ring. To examine the relationship between its structure and the inhibitory activity against DPP-IV. various analogues were synthesized and their activities were investitlaied- These results indicated that all of the functional groups on the piperidine ring were crucial to the DPP-IV inhibitory activity of sulphostin. and that the sulfonic acid group, which constructed the amino(sulfoamino)phosphinyl group, contributed to the stability of the compound. Moreover, those functional groups should be adjoined on the piperidine ring for the inhibitory acivity. The size of the nitrogen-containing heterocyclic ring including piperidine appeared to scarcely affect the activity. In the present study, the sulfonic acid-deficient five-membered ring analogue 27a showed the strongest inhibitory activity (IC50 = 11 nM). (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.10.036
  • 作为产物:
    描述:
    三乙烯二胺 作用下, 以 四氢呋喃 为溶剂, 以80%的产率得到(S)-3-(Cbz-氨基)-2-氧代氮杂烷
    参考文献:
    名称:
    分子内施陶丁格结扎:一种强大的闭合环方法,可形成中等大小的内酰胺。
    摘要:
    DOI:
    10.1002/anie.200351930
点击查看最新优质反应信息

文献信息

  • Rapid and Mild Lactamization Using Highly Electrophilic Triphosgene in a Microflow Reactor
    作者:Shinichiro Fuse、Keiji Komuro、Yuma Otake、Hisashi Masui、Hiroyuki Nakamura
    DOI:10.1002/chem.202100059
    日期:2021.5.12
    approaches that suffer from narrow substrate scope, much waste, and/or high cost. Inexpensive, less‐wasteful approaches mediated by highly electrophilic reagents are attractive, but there is an imminent risk of side reactions. Herein, a methods using highly electrophilic triphosgene in a microflow reactor that accomplishes rapid (0.5–10 s), mild, inexpensive, and less‐wasteful lactamization are described
    内酰胺是作为药物和候选药物必不可少的环状酰胺。常规内酰胺化包括酸介导和偶联剂介导的方法,这些方法受底物范围狭窄,浪费多和/或成本高。由高亲电试剂介导的廉价,浪费少的方法很有吸引力,但是有发生副反应的风险。本文描述了一种在微流反应器中使用高度亲电的三光气的方法,该方法可以快速(0.5-10 s),温和,廉价,内酰胺化程度低。方法A和B,使用N-甲基吗啉和N分别开发了-甲基咪唑。可以合成各种内酰胺和一个含有酸和/或不耐热官能团的环状肽,而产率高到高,而无需繁琐的纯化。通过使用微流技术,成功抑制了不良反应,并降低了处理三光气的风险。
  • Method for preparation of sulphostin and its analogue or intermediates thereof
    申请人:Nagai Masashi
    公开号:US20050020834A1
    公开(公告)日:2005-01-27
    A method for preparing a compound represented by the following general formula (5) where, n is an integer of 0 to 3; and Y represents a protecting group for an amino group, the method including the steps of reacting a compound represented by the following general formula (3) where n and Y are as described above, with a silylating agent, and subsequently reacting it with P (═O) T 3 , where T represents a halogen atom, and further with ammonia. A method for preparing an optically active intermediate of sulphostin or an analogue thereof, which is an optically active amine salt of an optically active compound represented by the following general formula (8) where n is an integer of 0 to 3; Y represents a protecting group for the amino group; and each configuration at C* and P* may be the same or different and indicates S or R, the method including reacting a compound represented by the following general formula (7) where n and Y are as described above; and the configuration of C* indicates either of S or R, with an optically active amine, and resolving the formed diastereomeric salt by fractional crystallization.
    以下是一个制备以下通用式(5)所表示的化合物的方法,其中n为0到3的整数;Y表示氨基保护基。该方法包括以下步骤:将以下通用式(3)所表示的化合物与硅基化试剂反应,然后再与P(═O)T3(其中T表示卤素原子)反应,最后再与氨反应。 以下是制备sulphostin或其类似物的光学活性中间体的方法,该中间体是以下通用式(8)所表示的光学活性化合物的光学活性胺盐,其中n为0到3的整数;Y表示氨基保护基;C*和P*的每个构型可以相同也可以不同,并表示S或R。该方法包括将以下通用式(7)所表示的化合物与光学活性胺反应,并通过分数结晶分离形成的对映异构体盐。
  • PROCESSES FOR PREPARATION OF SULPHOSTIN AND ITS ANALOGUES OR INTERMEDIATES THEREOF
    申请人:Nippon Kayaku Kabushiki Kaisha
    公开号:EP1457494A1
    公开(公告)日:2004-09-15
    A method for preparing a compound represented by the following general formula (5)    where, n is an integer of 0 to 3; and Y represents a protecting group for an amino group, the method including the steps of reacting a compound represented by the following general formula (3)    where n and Y are as described above, with a silylating agent, and subsequently reacting it with P (=O) T3, where T represents a halogen atom, and further with ammonia. A method for preparing an optically active intermediate of sulphostin or an analogue thereof, which is an optically active amine salt of an optically active compound represented by the following general formula (8) where n is an integer of 0 to 3; Y represents a protecting group for the amino group; and each configuration at C* and P* may be the same or different and indicates S or R, the method including reacting a compound represented by the following general formula (7) where n and Y are as described above; and the configuration of C* indicates either of S or R, with an optically active amine, and resolving the formed diastereomeric salt by fractional crystallization.
    一种制备由以下通式(5)代表的化合物的方法 其中,n 是 0 至 3 的整数;Y 代表氨基的保护基团,该方法包括以下步骤:使下一通式(3)所代表的化合物与硅烷化剂反应,其中 n 和 Y 如上所述。 其中,n 和 Y 如上所述,与硅烷化剂反应,然后与 P (=O) T3 反应,其中 T 代表卤素原子,再与氨反应。 一种制备舒磷定或其类似物的光学活性中间体的方法,该光学活性中间体是由下 列通式(8)代表的光学活性化合物的光学活性胺盐 其中 n 是 0 至 3 的整数;Y 代表氨基的保护基团;C* 和 P* 的每个构型可以相同或不同,并表示 S 或 R,该方法包括使下式通式(7)所代表的化合物反应 其中 n 和 Y 如上所述;C* 的构型表示 S 或 R,与光学活性胺反应,并通过分馏结晶分 解所形成的非对映异构盐。
  • SULPHOSTIN ANALOGUES AND PROCESSES FOR THE PREPARATION OF SULPHOSTIN AND ANALOGUES THEREOF
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP1184388B1
    公开(公告)日:2003-07-30
  • Brenner; Rickenbacher, Helvetica Chimica Acta, 1958, vol. 41, p. 181,186
    作者:Brenner、Rickenbacher
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐